Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/ sphingosine-1-phosphate 2 receptor-mediated ezrin activation

FASEB Journal

Volumn 27, Issue 8, 2013, Pages 3155-3166

  Gandy, K Alexa Orr ^a   Adada, Mohamad ^c   Canals, Daniel ^c   Carroll, Brittany ^c   Roddy, Patrick ^b   Hannun, Yusuf A ^c   Obeid, Lina M ^c,d  

^a Department of Molecular and Cellular Biology and Pathobiology ^*  (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Actin cytoskeleton; Moesin; Polarization; Radixin

Indexed keywords

EPIDERMAL GROWTH FACTOR; EZRIN; RECEPTOR; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE 2 RECEPTOR; THREONINE; UNCLASSIFIED DRUG; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; CYTOSKELETON PROTEIN; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; S1PR2 PROTEIN, HUMAN; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE;

ARTICLE; CELL INVASION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTERNALIZATION; PHOSPHORYLATION; POLARIZATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL MOTION; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HELA CELL LINE; IMMUNOBLOTTING; METABOLISM; MUTATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL MOVEMENT; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; HELA CELLS; HUMANS; IMMUNOBLOTTING; LYSOPHOSPHOLIPIDS; MICROSCOPY, CONFOCAL; MUTATION; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PYRAZOLES; PYRIDINES; RECEPTORS, LYSOSPHINGOLIPID; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84881163924     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-228460     Document Type: Article

References (64)

1. Neisch, A. L., and Fehon, R. G. (2011) Ezrin, radixin and moesin: key regulators of membrane-cortex interactions and signaling. Curr. Opin. Cell Biol. 23, 377-382
2. Kunda, P., Rodrigues, N. T., Moeendarbary, E., Liu, T., Ivetic, A., Charras, G., and Baum, B. (2012) PP1-mediated moesin dephosphorylation couples polar relaxation to mitotic exit. Curr. Biol. 22, 231-236
3. Li, J., Yang, H., Zhang, S., Yu, N., and Zhou, Q. (2007) [Expression and their significance of ezrin and E-cadherin in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 10, 183-187
4. Louvet-Vallee, S. (2000) ERM proteins: from cellular architecture to cell signaling. Biol. Cell 92, 305-316
5. Canals, D., Roddy, P., and Hannun, Y. A. (2012) Protein phosphatase 1alpha mediates ceramide-induced ERM Protein Dephosphorylation: a novel mechanism independent of phosphatidylinositol 4,5-biphosphate (PIP2) and myosin/erm phosphatase. J. Biol. Chem. 287, 10145-10155
6. Fehon, R. G., McClatchey, A. I., and Bretscher, A. (2010) Organizing the cell cortex: the role of ERM proteins. Nat. Rev. Mol. Cell Biol. 11, 276-287
7. Baumgartner, M., Sillman, A. L., Blackwood, E. M., Srivastava, J., Madson, N., Schilling, J. W., Wright, J. H., and Barber, D. L. (2006) The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors. Proc. Natl. Acad. Sci. U. S. A. 103, 13391-13396
8. Orr Gandy, K. A., Canals, D., Adada, M. M., Wada, M., Roddy, P. L., Snider, A., Hannun, Y. A., and Obeid, L. M. (2012) Sphingosine 1-phosphate induces filopodia formation through S1P2R activation of ERM proteins. Biochem. J. 449, 661-672
9. Canals, D., Jenkins, R. W., Roddy, P., Hernandez-Corbacho, M. J., Obeid, L. M., and Hannun, Y. A. (2010) Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane. J. Biol. Chem. 285, 32476-32485
10. Zeidan, Y. H., Jenkins, R. W., and Hannun, Y. A. (2008) Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ ceramide pathway. J. Cell Biol. 181, 335-350
11. Paugh, B. S., Paugh, S. W., Bryan, L., Kapitonov, D., Wilczynska, K. M., Gopalan, S. M., Rokita, H., Milstien, S., Spiegel, S., and Kordula, T. (2008) EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 22, 455-465
12. Hait, N. C., Sarkar, S., Le Stunff, H., Mikami, A., Maceyka, M., Milstien, S., and Spiegel, S. (2005) Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J. Biol. Chem. 280, 29462-29469
13. Balaban, N., Moni, J., Shannon, M., Dang, L., Murphy, E., and Goldkorn, T. (1996) The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim. Biophys. Acta 1314, 147-156
14. Cheng, L., Zhang, S., Alexander, R., Yao, Y., MacLennan, G. T., Pan, C. X., Huang, J., Wang, M., Montironi, R., and Lopez-Beltran, A. (2011) The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. Future Oncol. 7, 519-541
15. Batus, M., Fidler, M. J., and Bonomi, P. D. (2010) Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer. Expert Rev. Anticancer Ther. 10, 1589-1599
16. French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., and Smith, C. D. (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63, 5962-5969
17. Kharel, Y., Mathews, T. P., Gellett, A. M., Tomsig, J. L., Kennedy, P. C., Moyer, M. L., Macdonald, T. L., and Lynch, K. R. (2011) Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochem. J. 440, 345-353
18. Rodgers, A., Mormeneo, D., Long, J. S., Delgado, A., Pyne, N. J., and Pyne, S. (2009) Sphingosine 1-phosphate regulation of extracellular signal-regulated kinase-1/2 in embryonic stem cells. Stem Cells Dev. 18, 1319-1330
19. Bretscher, A. (1989) Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J. Cell Biol. 108, 921-930
20. Gould, K. L., Cooper, J. A., Bretscher, A., and Hunter, T. (1986) The protein-tyrosine kinase substrate, p81, is homologous to a chicken microvillar core protein. J. Cell Biol. 102, 660-669
21. Anelli, V., Gault, C. R., Cheng, A. B., and Obeid, L. M. (2008) Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and2. J. Biol. Chem. 283, 3365-3375
22. Spassieva, S., Bielawski, J., Anelli, V., and Obeid, L. M. (2007) Combination of C(17) sphingoid base homologues and mass spectrometry analysis as a new approach to study sphingolipid metabolism. Methods Enzymol. 434, 233-241
23. Estrada-Bernal, A., Lawler, S. E., Nowicki, M. O., Ray Chaudhury, A., and Van Brocklyn, J. R. (2011) The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells. J. Neurooncol. 102, 353-366
24. Sukocheva, O., Wadham, C., Holmes, A., Albanese, N., Verrier, E., Feng, F., Bernal, A., Derian, C. K., Ullrich, A., Vadas, M. A., and Xia, P. (2006) Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J. Cell Biol. 173, 301-310
25. Libotte, T., Kaiser, H. W., Alt, W., and Bretschneider, T. (2001) Polarity, protrusion-retraction dynamics and their interplay during keratinocyte cell migration. Exp. Cell Res. 270, 129-137
26. Takeuchi, K., and Ito, F. (2010) EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. FEBS J. 277, 316-326
27. Yotsumoto, F., Sanui, A., Fukami, T., Shirota, K., Horiuchi, S., Tsujioka, H., Yoshizato, T., Kuroki, M., and Miyamoto, S. (2009) Efficacy of ligand-based targeting for the EGF system in cancer. Anticancer Res. 29, 4879-4885
28. Lopez-Perez, M., and Salazar, E. P. (2006) A role for the cytoskeleton in STAT5 activation in MCF7 human breast cancer cells stimulated with EGF. Int. J. Biochem. Cell Biol. 38, 1716-1728
29. Chen, Z., Fadiel, A., Feng, Y., Ohtani, K., Rutherford, T., and Naftolin, F. (2001) Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor. Cancer 92, 3068-3075
30. Doll, F., Pfeilschifter, J., and Huwiler, A. (2005) The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MC F7. Biochim. Biophys. Acta 1738, 72-81
31. Hait, N. C., Bellamy, A., Milstien, S., Kordula, T., and Spiegel, S. (2007) Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 282, 12058-12065
32. Ren, L., Hong, S. H., Cassavaugh, J., Osborne, T., Chou, A. J., Kim, S. Y., Gorlick, R., Hewitt, S. M., and Khanna, C. (2009) The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 28, 792-802
33. Antoine-Bertrand, J., Ghogha, A., Luangrath, V., Bedford, F. K., and Lamarche-Vane, N. (2011) The activation of ezrin-radixinmoesin proteins is regulated by netrin-1 through Src kinase and RhoA/Rho kinase activities and mediates netrin-1-induced axon outgrowth. Mol. Biol. Cell. 22, 3734-3746
34. Chen, Y., Wang, D., Guo, Z., Zhao, J., Wu, B., Deng, H., Zhou, T., Xiang, H., Gao, F., Yu, X., Liao, J., Ward, T., Xia, P., Emenari, C., Ding, X., Thompson, W., Ma, K., Zhu, J., Aikhionbare, F., Dou, K., Cheng, S. Y., and Yao, X. (2011) Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma. Cancer Res. 71, 1721-1729
35. Kahsai, A. W., Zhu, S., and Fenteany, G. (2010) G proteincoupled receptor kinase 2 activates radixin, regulating membrane protrusion and motility in epithelial cells. Biochim. Biophys. Acta 1803, 300-310
36. Nakamura, N., Oshiro, N., Fukata, Y., Amano, M., Fukata, M., Kuroda, S., Matsuura, Y., Leung, T., Lim, L., and Kaibuchi, K. (2000) Phosphorylation of ERM proteins at filopodia induced by Cdc42. Genes Cells5, 571-581
37. Gorshkova, I., He, D., Berdyshev, E., Usatuyk, P., Burns, M., Kalari, S., Zhao, Y., Pendyala, S., Garcia, J. G., Pyne, N. J., Brindley, D. N., and Natarajan, V. (2008) Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Ra c1. J. Biol. Chem. 283, 11794-11806
38. Schenten, V., Melchior, C., Steinckwich, N., Tschirhart, E. J., and Brechard, S. (2011) Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/ A9. J. Leukoc. Biol. 89, 587-596
39. Medlin, M. D., Staus, D. P., Dubash, A. D., Taylor, J. M., and Mack, C. P. (2010) Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. Arterioscler. Thromb. Vasc. Biol. 30, 1779-1786
40. Adyshev, D. M., Moldobaeva, N. K., Elangovan, V. R., Garcia, J. G., and Dudek, S. M. (2011) Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement. Cell. Signal. 23, 2086-2096
41. Kruser, T. J., and Wheeler, D. L. (2010) Mechanisms of resistance to HER family targeting antibodies. Exp. Cell Res. 316, 1083-1100
42. Kim, S., Han, J., Kim, J. S., Kim, J. H., Choe, J. H., Yang, J. H., Nam, S. J., and Lee, J. E. (2011) Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells. Anticancer Res. 31, 3767-3773
43. Young, N., Pearl, D. K., and Van Brocklyn, J. R. (2009) Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol. Cancer Res. 7, 23-32
44. Yamaguchi, H., Kitayama, J., Takuwa, N., Arikawa, K., Inoki, I., Takehara, K., Nagawa, H., and Takuwa, Y. (2003) Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem. J. 374, 715-722
45. Bao, M., Chen, Z., Xu, Y., Zhao, Y., Zha, R., Huang, S., Liu, L., Chen, T., Li, J., Tu, H., and He, X. (2012) Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Liver Int. 32, 331-338
46. Li, M. H., Sanchez, T., Milne, G. L., Morrow, J. D., Hla, T., and Ferrer, F. (2009) S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor. J. Urol. 181, 1347-1352
47. Donati, C., Nincheri, P., Cencetti, F., Rapizzi, E., Farnararo, M., and Bruni, P. (2007) Tumor necrosis factor-alpha exerts promyogenic action in C2C12 myoblasts via sphingosine kinase/ S1P2 signaling. FEBS Lett. 581, 4384-4388
48. Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J., and Prior, T. W. (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 64, 695-705
49. Van Brocklyn, J., Letterle, C., Snyder, P., and Prior, T. (2002) Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. Cancer Lett. 181, 195-204
50. Stiess, M., and Bradke, F. (2011) Neuronal polarization: the cytoskeleton leads the way. Dev. Neurobiol. 71, 430-444
51. Pullar, C. E., Baier, B. S., Kariya, Y., Russell, A. J., Horst, B. A., Marinkovich, M. P., and Isseroff, R. R. (2006) beta4 integrin and epidermal growth factor coordinately regulate electric fieldmediated directional migration via Ra c1. Mol. Biol. Cell 17, 4925-4935
52. Lynch, J. A., Peel, A. D., Drechsler, A., Averof, M., and Roth, S. (2010) EGF signaling and the origin of axial polarity among the insects. Curr. Biol. 20, 1042-1047
53. Kagesawa, T., Nakamura, Y., Nishikawa, M., Akiyama, Y., Kajiwara, M., and Matsuno, K. (2008) Distinct activation patterns of EGF receptor signaling in the homoplastic evolution of eggshell morphology in genus Drosophila. Mech. Devel. 125, 1020-1032
54. Duchek, P., and Rorth, P. (2001) Guidance of cell migration by EGF receptor signaling during Drosophila oogenesis. Science 291, 131-133
55. Saotome, I., Curto, M., and McClatchey, A. I. (2004) Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev. Cell 6, 855-864
56. Rosenfeldt, H. M., Hobson, J. P., Maceyka, M., Olivera, A., Nava, V. E., Milstien, S., and Spiegel, S. (2001) EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. FASEB J. 15, 2649-2659
57. Asghar, U., Hawkes, E., and Cunningham, D. (2010) Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer. Clin. Colorectal Cancer 9, 274-281
58. Domingo, G., Perez, C. A., Velez, M., Cudris, J., Raez, L. E., and Santos, E. S. (2010) EGF receptor in lung cancer: a successful story of targeted therapy. Expert Rev. Anticancer Ther. 10, 1577-1587
59. Brakch, N., Dormond, O., Bekri, S., Golshayan, D., Correvon, M., Mazzolai, L., Steinmann, B., and Barbey, F. (2010) Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. Eur. Heart J. 31, 67-76
60. Nunes, J., Naymark, M., Sauer, L., Muhammad, A., Keun, H., Sturge, J., Stebbing, J., Waxman, J., and Pchejetski, D. (2012) Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection. Br. J. Cancer 106, 909-915
61. Zhai, J. W., Yang, X. G., Yang, F. S., Hu, J. G., and Hua, W. X. (2010) Expression and clinical significance of Ezrin and Ecadherin in esophageal squamous cell carcinoma. Chin. J. Cancer 29, 317-320
62. Musial, J., Sporny, S., and Nowicki, A. (2007) Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer. Pol. J. Pathol. 58, 235-243
63. Wang, L., Gao, Y., Tu, Q., and Hong, J. (2010) [Expression of Ezrin and E-cadherin in nasopharyngeal carcinoma and its significance]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35, 969-975
64. Cui, Y., Li, T., Zhang, D., and Han, J. (2010) Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma. Cancer Invest. 28, 242-247